Combination chemotherapy with capecitabine (C), irinotecan (I), oxaliplatin (O), and bevacizumab (B; XELOXIRIA) as first-line treatment of metastatic colorectal cancer (MCRC): Preliminary results of a phase I-II trial.

被引：0
|
作者：
Bazarbashi, S. [1 ]
Aljubran, A. H. [1 ]
Soudy, H. [1 ]
Darwish, A. [1 ]
Eltigani, A. [1 ]
Nabil-Ahmed, M. [1 ]
Edesa, W. [1 ]
Almubarak, M. [1 ]
Abu Sabaa, A. [1 ]
Shoukri, M. [1 ]
机构：
[1] King Faisal Specialist Hosp & Res Ctr, Riyadh 11211, Saudi Arabia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e14073
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14073
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Oxaliplatin, irinotecan and capecitabine for first line treatment of advanced metastatic colorectal cancer (CRC):: A phase I-II trial by the Swiss Group for Clinical Cancer Research (SAKK 41/03)
    Popescu, R.
    Roth, A.
    Ruhstaller, T.
    Widmer, L.
    Uhlmann, C.
    Cathomas, R.
    Koebede, D.
    Lanz, D.
    Simcock, M.
    Von Moos, R.
    ANNALS OF ONCOLOGY, 2008, 19 : 10 - 10
  • [42] Capecitabine (C), in combination with irinotecan (I) and oxallplatin (O) (XELOXIRI) as first-line treatment of metastatic colorectal cancer (MCRC): results of a pilot study by the Gruppo Oncologico Nord-Ovest (GONO)
    Bursi, S.
    Masi, G.
    Loupakis, F.
    Antonuzzo, A.
    Chiara, S.
    Pfanner, E.
    Petrini, I.
    Barletta, M. T.
    Baldi, G. G.
    Falcone, A.
    EJC SUPPLEMENTS, 2007, 5 (04): : 255 - 255
  • [43] Bi-weekly XELOX (capecitabine/oxaliplatin) plus bevacizumab as first-line treatment of metastatic colorectal cancer (mCRC): PHOENIX trial
    Nagata, N.
    Okada, T.
    Okazaki, S.
    Sato, S.
    Kin, H.
    Nakamura, M.
    Kunieda, K.
    Oba, K.
    Sakamoto, J.
    Mishima, H.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S559 - S559
  • [44] Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial
    Masi, Gianluca
    Loupakis, Fotios
    Salvatore, Lisa
    Fornaro, Lorenzo
    Cremolini, Chiara
    Cupini, Samanta
    Ciarlo, Andrea
    Del Monte, Francesca
    Cortesi, Enrico
    Amoroso, Domenico
    Granetto, Cristina
    Fontanini, Gabriella
    Sensi, Elisa
    Lupi, Cristiana
    Andreuccetti, Michele
    Falcone, Alfredo
    LANCET ONCOLOGY, 2010, 11 (09): : 845 - 852
  • [45] EFFICACY AND SAFETY OF CETUXIMAB, OXALIPLATIN AND CAPECITABINE AS FIRST-LINE THERAPY FOR METASTATIC COLORECTAL CANCER (MCRC): RESULTS OF A PHASE II STUDY
    Barroso, S.
    Sanches, E.
    Ferreira, J.
    Passos, M.
    Sa, A.
    Nabico, R.
    SottoMayor, C.
    Santo, Espirito J.
    San-Bento, R.
    ANNALS OF ONCOLOGY, 2009, 20 : 65 - 65
  • [46] Efficacy and safety of cetuximab, oxaliplatin, and capecitabine as first-line therapy for metastatic colorectal cancer (mCRC): Results of a phase II study
    Barroso, S. A.
    Sanches, E.
    Ferreira, M.
    Passos, M.
    Sa, A.
    Nabico, R.
    Sotto-Mayor, C.
    Santo, J. Espirito
    San-Bento, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [47] A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancer
    Rea, DW
    Nortier, JWR
    Huinink, WWT
    Falk, S
    Riche, DJ
    Maughan, T
    Groenewegen, G
    Smit, JM
    Steven, N
    Bakker, JM
    Semiond, D
    Kerr, DJ
    Punt, CJA
    ANNALS OF ONCOLOGY, 2005, 16 (07) : 1123 - 1132
  • [48] Phase II study of bevacizumab in combination with capecitabine as first-line treatment in elderly patients with metastatic colorectal cancer
    Vrdoljak, Eduard
    Omrcen, Tomislav
    Boban, Marijo
    Hrabar, Andina
    ANTI-CANCER DRUGS, 2011, 22 (02) : 191 - 197
  • [49] Bevacizumab in Combination with Capecitabine plus Irinotecan as First-Line Therapy in Metastatic Colorectal Cancer: A Pooled Analysis of 2 Phase II
    Garcia Alfonso, Pilar
    Munoz Martin, Andres
    Alvarez Suarez, Sonsoles
    Blanco Codeidido, Monserrat
    Mondejar Solis, Rebeca
    Tapia Rico, Gonzalo
    Lopez Martin, Pilar
    Martin, Miguel
    ONKOLOGIE, 2013, 36 (06): : 363 - 367
  • [50] Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients
    Bécouarn, Y
    Ychou, M
    Ducreux, M
    Borel, C
    Bertheault-Cvitkovic, F
    Seitz, JF
    Nasca, S
    Nguyen, TD
    Paillot, B
    Raoul, JL
    Duffour, J
    Fandi, A
    Dupont-André, G
    Rougier, P
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) : 2739 - 2744
12345